To: Board of Supervisors
From: Dr. Grant Colfax, Health Services Director
Report Title: Purchase Order with Boston Scientific Corporation
☒Recommendation of the County Administrator ☐ Recommendation of Board Committee
RECOMMENDATIONS:
APPROVE and AUTHORIZE the Purchasing Agent, or designee, to execute, on behalf of the Health Services Director, a blanket purchase order with Boston Scientific Corporation in an amount not to exceed $1,300,000 for the purchase of vascular, urology, endoscopy, and other supplies as needed for Contra Costa Regional Medical Center (CCRMC) for the period of September 1, 2025 through August 31, 2028.
FISCAL IMPACT:
Approval of this action will result in expenditures of up to $1,300,000 over a three-year period and will be funded by Hospital Enterprise Fund I revenues.
BACKGROUND:
Boston Scientific Corporation provides medical devices used in a wide range of specialties, including cardiology, endoscopy, urology, neuromodulation, and peripheral interventions. CCRMC uses interventional urology products from Boston Scientific that are designed for diagnosing and treating urological conditions with minimally invasive solutions. These include stents, laser systems, resectoscopes, and neuromodulation devices for conditions like Benign Prostatic Hyperplasia (BPH), kidney stones, urinary incontinence, and bladder cancer. The products aim to reduce the need for surgery, improve outcomes, and shorten recovery times for patients.
On February 8, 2022 the Board of Supervisors approved agenda item C.39 to execute a purchase order with Boston Scientific Corporation in the amount of $600,000 for the purchase of vascular, urology, endoscopy, and other supplies for CCRMC for the period from January 1, 2022 through May 31, 2023. CCRMC terminated the ordering process with Boston Scientific Corporation starting June 1, 2023 to allow time for a new purchase order to be established.
On July 11, 2023 the Board of Supervisors approved agenda C.98 to execute purchase order #28564 with Boston Scientific Corporation in the amount of $600,000 for the purchase of vascular, urology, endoscopy, and other supplies for CCRMC for the period of July 1, 2023 through May 31, 2025.
On February 25, 2025 the Board of Supervisors approved agenda C.103 to amend purchase order #28564 with Boston Scientific Corporation to increase the amount to a new payment limit of $784,000 with no change to the original term of July 1, 2023 through May 31, 2025.
On September 16, 2025 CCRMC plans to request that the Board of Supervisors approve payment to Boston Scientific Corporation for products provided to CCRMC during the period of June 1, 2025 through August 31, 2025.
Boston Scientific Corporation is a member of the Vizient Group Purchasing Organization (GPO) and per Administrative Bulletin 600.3, GPO members are exempt from solicitation requirements.
CONSEQUENCE OF NEGATIVE ACTION:
If this action is not approved, CCRMC will not be able to acquire the specialty supplies essential for performing critical surgeries, potentially compromising patient care and treatment outcomes.